Mark S. Forsythe - Concepedia

Author

Mark S. Forsythe

Wilmington University

Also Known As

M S Forsythe, M. Forsythe, M. S. Forsythe, M.S. Forsythe, Mark Forsythe, Mark S Forsythe, Mark S. Forsythe

Publications

630

Citations

H-Index

Concepts

All Affiliations

Wilmington University DuPont (United States)Experimental Station

About

Mark S. Forsythe is an author at Wilmington University specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	224
2	Pharmacology	7	7	224
3	Biochemistry	4	4	180
4	Immunology	3	3	61
5	Natural Sciences	2	2	114

Mark S. Forsythe

Publications

597

Citations

H-Index

Page 1

	Year	Citations
Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. Shaker A. Mousa, Jeffrey M. Bozarth, Mark S. Forsythe, Circulation	1994	103
Comparative In Vitro Efficacy of Different Platelet Glycoprotein IIb/IIIa Antagonists on Platelet-Mediated Clot Strength Induced by Tissue Factor With Use of Thromboelastography Shaker A. Mousa, Sandeep Khurana, Mark S. Forsythe Arteriosclerosis Thrombosis and Vascular Biology	2000	77
Disubstituted Indazoles as Potent Antagonists of the Integrin α<sub>v</sub>β<sub>3</sub> Douglas G. Batt, Joseph J. Petraitis, Gregory C. Houghton, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceBiochemistryMedicine	1999	72
Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754 Shaker A. Mousa, Mark S. Forsythe, William Lorelli, Coronary Artery Disease	1996	47
Ca++ utilization in the constriction of rat aorta to stimulation of protein kinase C by phorbol dibutyrate. Andrew T. Chiu, J M Bozarth, Mark S. Forsythe, Journal of Pharmacology and Experimental Therapeutics	1987	45
Antiplatelet Efficacy and Specificity of DMP728, a Novel Platelet GPIIb/llla Receptor Antagonist Shaker A. Mousa, Jeff M. Bozarth, Mark S. Forsythe, Cardiology PharmacotherapyPlatelet Gpiib/iiiaAntiplatelet EfficacyThrombosisMedicinal Chemistry	1993	42
Effect of Single Oral Dose of Aspirin on Human Platelet Functions and Plasma Plasminogen Activator Inhibitor-1 Shaker A. Mousa, Mark S. Forsythe, Jeff M. Bozarth, Cardiology	1993	41
Antiplatelet Efficacy of XV459, A Novel Nonpeptide Platelet GPIIb/IIIa Antagonist: Comparative Platelet Binding Profiles with c7E3 Shaker A. Mousa, Jeffrey M. Bozarth, William Lorelli, Journal of Pharmacology and Experimental Therapeutics	1998	41
DISSOCIATION BETWEEN THE ANTI-AGGREGATORY & ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN αIIbβ3 (GPIIb/IIIa) ANTAGONISTS, c7E3 AND DMP728 Peter W. Tsao, Mark S. Forsythe, Shaker A. Mousa Thrombosis Research InflammationThrombosisSignal TransductionBiochemistryBlood Platelet	1997	38
Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide Peter W. Tsao, Jeffrey M. Bozarth, Sharon Jackson, Thrombosis Research Signal TransductionBiochemistryG Protein-coupled ReceptorMedicineBlood Platelet	1995	28

Page 1